Trasis

Booth: A19

Bronze Sponsor

Belgium

Trasis is an innovative and trusted partner in nuclear medicine and radiopharmacy, with more than 20 years of experience supporting molecular imaging and targeted therapies. The company develops cutting-edge solutions that improve the diagnosis and treatment of major diseases, including cancer, neurological, and cardiological disorders.

With GMP-certified manufacturing facilities in Belgium and France, Trasis provides comprehensive CDMO services ranging from early process development and chemical synthesis to API and precursor manufacturing, formulation, and sterile fill & finish. Its expertise covers small molecules, peptides, macrocycles, chelators, cold kits, and radiopharmaceutical consumables, supported by strong regulatory know-how compliant with FDA, EMA, and PMDA requirements.

Beyond manufacturing, Trasis offers custom development, tracer development, equipment engineering, training, and dedicated customer support. Driven by innovation, collaboration, and scientific excellence, Trasis supports projects from early research through clinical development and commercial production, helping advance the future of nuclear medicine worldwide.